Article
Methylation and mutational analysis of p27(kip1) in prostate carcinoma.
The Prostate - 15 Sept 2001
Kibel A S, Christopher M, Faith D A, Bova G S, Goodfellow P J, Isaacs W B
Abstract excerpt
BACKGROUND: We have previously identified 12p12-13 as a region of frequent genetic loss in prostate carcinoma. A candidate tumor suppressor gene at this locus is the cyclin dependent kinase inhibitor p27(kip1), which has been implicated as a marker of aggressive prostate carcinoma. Herein, we examine metastatic prostate tumors, xenografts, and cell lines for gene inactivation via mutational inactivation or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
